BridgeMD
New treatment option for Acute Lymphoblastic Leukaemias (ALL)
Official title Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
ClinicalTrials.gov ID: NCT07313878
What this study is testing
- What it's testing
- With increasing survival rates in pediatric oncology, reports of long-term side effects persisting decades after treatment are also rising. Clinically evident nephropathies occur in about 5.5% of survivors more than five years after therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 17
You may be able to join if
- Diagnosed acute lymphatic leukemia
- From 3 years to \< 18 years
- completed oncological treatment or treatment day \< 50 according to therapy protocol and no administration of CPM before first examination.
You likely can't join if
- Known allergic disposition to SonoVue / other contrast agents
- Tattoo in the area of the examination field
- Pregnancy
- Breastfeeding mothers
- Contraindication for the use of Sonovue
- Critical condition
See the full eligibility criteria
- Diagnosed acute lymphatic leukemia
- From 3 years to \< 18 years
- completed oncological treatment or treatment day \< 50 according to therapy protocol and no administration of CPM before first examination.
- Known allergic disposition to SonoVue / other contrast agents
- Tattoo in the area of the examination field
- Pregnancy
- Breastfeeding mothers
- Contraindication for the use of Sonovue
- Critical condition
- Known clinically evident renal impairment
The study team makes the final eligibility decision.
Where it's taking place
- Erlangen, Baveria, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erlangen, Baveria, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.